Topic: Immunobridging

1 chapters across the catalog

Flexitarianism
Episode 1478 54:02 - 57:18

1478: Flexitarianism

Peter McCullough, Vaccine Clinical Outcomes Uncertainty

Dr. Peter McCullough warns that new multivalent vaccines are being released without randomized clinical trials showing definitive therapeutic outcomes. Instead, regulators are relying on "immunobridging" studies that measure antibody levels. There is ongoing debate regarding the marketing dominance of Pfizer over competitors like AstraZeneca and Moderna.